Literature DB >> 34774576

Ocular Manifestations in Patients with Fanconi Anemia: A Single-Center Experience Including 106 Patients.

Christie Michelle Graf1, Samantha Nichele2, Renata Bigolin Siviero3, Gisele Loth2, Joanna Paula Trennepohl2, Mariana Tosato Zinher4, Alexandre Grandinetti3, Daniela Vandresen Pilonetto5, Ricardo Pasquini2, Ana Tereza Ramos Moreira4, Carmem Bonfim2.   

Abstract

OBJECTIVES: To describe the prevalence of acquired ocular manifestations in patients with Fanconi anemia (FA) and to describe and correlate the congenital ocular malformations with the genetic subtypes of the disease. STUDY
DESIGN: This is a cross-sectional observational study of 106 consecutive patients with confirmed diagnosis of FA who were followed at the Hematopoietic Stem Cell Transplantation (HSCT) Service at the Federal University of Paraná, Curitiba, Parana, Brazil. Participants underwent a complete ophthalmologic evaluation and 84 patients underwent ocular ultrasound examination. This study was conducted between November 2014 and August 2017.
RESULTS: The patients ranged in age from 6 months to 43 years of age. Microphthalmia was the most common congenital ocular abnormality (95.2%). A decrease in anthropometric measurements was observed, including palpebral fissure length (78/103 patients [76.5%]), microcornea (48/103 patients [46.6%]), and ptosis (31/103 patients [30.1%]). We identified a new ophthalmic condition in 15 patients with FA, that is, epiretinal tissue on the optic disc. The genetic subtype was identified in 78 patients (79.6%), the FA-A subtype was most prevalent (50%). The most common acquired ocular manifestation (non-graft-versus-host disease [GVHD] related) in patients who did not undergo HSCT (n = 44) was limbal neovascularization (13.6%), whereas in patients who underwent HSCT (n = 62), the GVHD-related manifestation was ocular GVHD (51.6%). The most frequent symptom of ocular GVHD was keratoconjunctivitis sicca (29%).
CONCLUSIONS: Several ocular manifestations were identified in patients with FA.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Fanconi anemia; genetic subtypes; ocular manifestations

Mesh:

Year:  2021        PMID: 34774576     DOI: 10.1016/j.jpeds.2021.11.013

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  3 in total

1.  Deep-Learning-Based Hemoglobin Concentration Prediction and Anemia Screening Using Ultra-Wide Field Fundus Images.

Authors:  Xinyu Zhao; Lihui Meng; Hao Su; Bin Lv; Chuanfeng Lv; Guotong Xie; Youxin Chen
Journal:  Front Cell Dev Biol       Date:  2022-05-19

2.  Fanconi Anemia Patients from an Indigenous Community in Mexico Carry a New Founder Pathogenic Variant in FANCG.

Authors:  Pedro Reyes; Benilde García-de Teresa; Ulises Juárez; Fernando Pérez-Villatoro; Moisés O Fiesco-Roa; Alfredo Rodríguez; Bertha Molina; María Teresa Villarreal-Molina; Jorge Meléndez-Zajgla; Alessandra Carnevale; Leda Torres; Sara Frias
Journal:  Int J Mol Sci       Date:  2022-02-20       Impact factor: 5.923

Review 3.  Fanconi anemia and dyskeratosis congenita/telomere biology disorders: Two inherited bone marrow failure syndromes with genomic instability.

Authors:  Moisés Ó Fiesco-Roa; Benilde García-de Teresa; Paula Leal-Anaya; Renée van 't Hek; Talia Wegman-Ostrosky; Sara Frías; Alfredo Rodríguez
Journal:  Front Oncol       Date:  2022-08-25       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.